Solvay Pharmaceuticals, Gmbh

Claus Rudolf Steinborn

Matthias Straub

Friederike Henniges

Egbertus Hendrikus Evert Biesheuvel

Heinz Guenter Krause

Werner Cautreels

Diethard Schwanitz

Steven David Caras

Suntje Sander-Struckmeier

Johannes Wilhelmus Catharine Maria Jansen

Werner L M Cautreels

Albertus Hermannus Dirk Plekkenpol

Martin A Rudmann

Michiel Henricus De Vries

The use of physiologically acceptable enzyme mixtures having lipolytic, proteolytica and amylolytic activity, of microbial or animal origin, preferably digestive enzyme mixtures such as pancreatin or digestive enzyme mixtures containing pancreatin, for the treatment of diabetes. The invention also relates to the production of pharmaceutical compositions suitable for such treatment. A preferred variant of the invention relates to use of this enzyme mixture having lipolytic, proteolytic and amylolytic activity, especially digestive enzyme mixtures such as pancreatin or digestive enzyme mixtures containing pancreatin, for the adjuvant treatment of type I or type II diabetes mellitus.

Method for the treatment of diabetes

The present invention relates to the use of 3,7-diazabicyclo[3,3,1]nonane compounds, preferably of 9,9-alkylene-3,7-diazabicyclo[3,3,1]nonane compounds, and most preferably to the use of tedisamil, and the physiologically acceptable acid addition salts and/or solvates thereof, in the form of a liquid pharmaceutical preparation for the treatment and/or inhibition of anti-arrhythmic events in human patients, preferably in conversion of recent onset of atrial fibrillation or flutter to normal sinus rhythm in humans. Furthermore, the invention concerns related methods of treatment and pharmaceutical products.

Liquid pharmaceutical formulations containing 3,7-diazabicyclo[3,3,1]nonane compounds and methods of treatment relating to anti-arrhythmic events

The present invention relates to the use of cilansetron for the treatment of non-obstipative male IBS patients.

Medicament containing cilansetron for the treatment of non-obstipative male irritable bowel syndrome patients

Growing community of inventors

Seelze, Germany

Claus Rudolf Steinborn